Vitaspring Biomedical (VSBC) EV to CFO (2020 - 2026)
Vitaspring Biomedical's (VSBC) EV to CFO stood at 194.64 in fiscal Q2 2027 (quarter ended Jul 31, 2026), down 60.5% from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) EV to CFO (2020 - 2026) Analysis & Trends
On a TTM basis, Vitaspring Biomedical's EV to CFO came in at 193.48 as of Jul 31, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 194.64 |
| Apr 30, 2026 | 493.10 |
| Jul 31, 2022 | 12,947.11 |
| Apr 30, 2021 | 6,933.24 |
| Oct 31, 2020 | 1.00 Mn |
| Jul 31, 2020 | 353,436.00 |
API Access
Vitaspring Biomedical EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();